Publications

Title

Author

Year

Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis.

Beck, CR; McKenzie, BC; Hashim, AB; HARRIS, RC; Zanuzdana, A; Agboado, G; Orton, E; Béchard-Evans, L; Morgan, G; Stevenson, C; Weston, R; Mukaigawara, M; Enstone, J; Augustine, G; Butt, M; Kim, S; Puleston, R; Dabke, G; Howard, R; O'Boyle, J; O'Brien, M; Ahyow, L; Denness, H; Farmer, S; Figureroa, J; ... Nguyen-Van-Tam, JS.

2013

Influenza and other respiratory viruses, (2013).7 Supp Suppl 10.1111/irv.12084.

Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review.

Dolan, GP; HARRIS, RC; Clarkson, M; Sokal, R; Morgan, G; Mukaigawara, M; Horiuchi, H; Hale, R; Stormont, L; Béchard-Evans, L; Chao, Y-S; Eremin, S; Martins, S; Tam, J; Peñalver, J; Zanuzadana, A; Nguyen-Van-Tam, JS;

2013

Influenza and other respiratory viruses, (2013).7 Suppl 2, 10.1111/irv.12087.

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review.

Fesenfeld, M; Hutubessy, R; JIT, M;

2013

Vaccine, (2013).31 37 10.1016/j.vaccine.2013.06.060.

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects.

Wigle, J; Coast, E; WATSON-JONES, D;

2013

Vaccine, (2013).31 37 10.1016/j.vaccine.2013.06.016.

Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies.

Baidjoe, A; STONE, W; Ploemen, I; Shagari, S; GRIGNARD, L; Osoti, V; Makori, E; Stevenson, J; Kariuki, S; SUTHERLAND, C; Sauerwein, R; COX, J; DRAKELEY, C; Bousema, T;

2013

Malaria journal, (2013).12 1 10.1186/1475-2875-12-272.

Negotiating vaccine acceptance in an era of reluctance.

LARSON, HJ;

2013

Human vaccines & immunotherapeutics, (2013).9 8 10.4161/hv.25932.

The impact of targeting all elderly persons in England and Wales for yearly influenza vaccination: excess mortality due to pneumonia or influenza and time trend study.

MANN, AG; MANGTANI, P; Russell, CA; WHITTAKER, JC;

2013

BMJ open, (2013).3 8 10.1136/bmjopen-2013-002743.

Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity.

TETTEH, KK A; Osier, FH A; Salanti, A; Kamuyu, G; DROUGHT, L; Failly, M; Martin, C; Marsh, K; CONWAY, DJ;